What is the ROE (Return on Equity) of Rezolute this year?
The ROE of Rezolute this year is -0.45 undefined.
Rezolute ROE 2024
Rezolute ROE
-0.45
Ticker
RZLT
ISIN
US76200L3096
In 2024, Rezolute's return on equity (ROE) was -0.45, a 62.28% increase from the -0.27 ROE in the previous year.
Rezolute Aktienanalyse
What does Rezolute do?
Rezolute Inc. is a bio-pharmaceutical company that was founded in 2010 in California. The company specializes in the research and development of innovative therapies for the treatment of rare metabolic and endocrine diseases. The business model of Rezolute is to develop innovative solutions and treatment approaches for diseases that currently have insufficient treatment options. The company is actively working to expand its product pipeline and explore new treatment methods in order to give hope and prospects for a better quality of life to suffering patients. Rezolute is active in three main areas: diabetes and metabolic diseases, diseases of the endocrine system, and protein-based therapy platforms. Each of these areas is of great importance in combating rare diseases that are often overlooked by the pharmaceutical industry. The diabetes and metabolic diseases category is the core business of Rezolute Inc. The company strives to develop innovative therapies for the treatment of diabetes itself and its comorbidities. This includes diseases of the cardiovascular system and kidney diseases, which are common among diabetes patients. In the category of endocrine diseases, the company is working on the development of targeted therapies for the treatment of diseases such as hypothyroidism (an underactive thyroid) and hypopituitarism (a deficiency of hormones produced by the pituitary gland). These diseases are often overlooked by the pharmaceutical industry as they occur less frequently compared to other diseases. The protein-based therapy platforms are technologically advanced and have the potential to offer new treatment options. Rezolute utilizes its own proprietary technologies for the development of immunoglobulins and drugs that specifically target certain molecules. The company is also researching compounds that can influence the immune system to combat inflammation and autoimmune diseases. Rezolute currently has several therapy options in development. The company is working on RZ358, an oral insulin formulation for the treatment of diabetes; RZ402, a drug for the treatment of pancreatitis (inflammation of the pancreas); and RZ402, a drug for the treatment of pancreatitis (inflammation of the pancreas). The company has also obtained orphan drug status to develop RZ358, its innovative therapy for the treatment of Congenital Hyperinsulinism (CHI), a rare, congenital endocrine disorder. Rezolute has established itself as an important player in the global bio-pharmaceutical market. The company is committed to improving the lives of patients suffering from rare diseases by developing innovative treatment options. With a dedicated team of scientists and researchers, the company strives to push the boundaries of science and develop the next generation of innovative therapies that have the potential to improve the lives of patients. Rezolute ist eines der beliebtesten Unternehmen auf Eulerpool.com.ROE Details
Decoding Rezolute's Return on Equity (ROE)
Rezolute's Return on Equity (ROE) is a fundamental metric evaluating the company's profitability relative to its equity. Calculated by dividing net income by shareholder's equity, ROE illustrates how effectively the company is generating profits from shareholders’ investments. A higher ROE represents enhanced efficiency and profitability.
Year-to-Year Comparison
Analyzing Rezolute's ROE on a yearly basis aids in tracking its profitability trends and financial performance. An increasing ROE suggests enhanced profitability and value generation for shareholders, whereas a declining ROE may indicate issues in profit generation or equity management.
Impact on Investments
Rezolute's ROE is instrumental for investors assessing the company's profitability, efficiency, and investment attractiveness. A robust ROE indicates the firm’s adeptness at converting equity investments into profits, thereby enhancing its appeal to potential and current investors.
Interpreting ROE Fluctuations
Changes in Rezolute’s ROE can emanate from variations in net income, equity capital, or both. These fluctuations are scrutinized to evaluate management’s effectiveness, financial strategies, and the inherent risks and opportunities, aiding investors in making informed decisions.
Frequently Asked Questions about Rezolute stock
How has the Return on Equity (ROE) of Rezolute developed compared to the previous year?
The ROE of Rezolute has increased by 62.28% increased compared to the previous year.
What impact does a high ROE (Return on Equity) have on investors of Rezolute?
A high ROE indicates that Rezolute generates good returns on capital and is successful in monetizing its investments. This is a positive indicator for investors.
What impact does a low ROE (Return on Equity) have on investors of Rezolute?
A low ROE can indicate that Rezolute is having difficulties monetizing its investments successfully and can be a negative signal for investors.
How does a change in the ROE (Return on Equity) of Rezolute affect the company?
A change in ROE (Return on Equity) of Rezolute can be an indicator of the financial performance of the company and demonstrate how successful the company is compared to other companies in the same industry.
How to calculate the ROE (Return on Equity) of Rezolute?
The ROE (Return on Equity) is calculated by dividing the company's profit by the total equity. The formula is: ROE = Profit / Total equity.
Which factors influence the ROE (Return on Equity) of Rezolute?
Some factors that can influence Rezolute's Return on Equity (ROE) include the efficiency in using equity, the profitability of the company, and the financing structure.
What strategic measures can take to improve the ROE (Return on Equity)?
To improve the Return on Equity (ROE), can take measures such as cost savings, increasing revenue, improving efficiency in the use of equity, and making changes in the financing structure. It is important for the company to conduct a thorough review of its financial situation to determine the best strategic actions to improve ROE.
How much dividend does Rezolute pay?
Over the past 12 months, Rezolute paid a dividend of . This corresponds to a dividend yield of about . For the coming 12 months, Rezolute is expected to pay a dividend of 0 USD.
What is the dividend yield of Rezolute?
The current dividend yield of Rezolute is .
When does Rezolute pay dividends?
Rezolute pays a quarterly dividend. This is distributed in the months of .
How secure is the dividend of Rezolute?
Rezolute paid dividends every year for the past 0 years.
What is the dividend of Rezolute?
For the upcoming 12 months, dividends amounting to 0 USD are expected. This corresponds to a dividend yield of 0 %.
In which sector is Rezolute located?
Rezolute is assigned to the 'Health' sector.
Wann musste ich die Aktien von Rezolute kaufen, um die vorherige Dividende zu erhalten?
To receive the latest dividend of Rezolute from 10/8/2024 amounting to 0 USD, you needed to have the stock in your portfolio before the ex-date on 10/8/2024.
When did Rezolute pay the last dividend?
The last dividend was paid out on 10/8/2024.
What was the dividend of Rezolute in the year 2023?
In the year 2023, Rezolute distributed 0 USD as dividends.
In which currency does Rezolute pay out the dividend?
The dividends of Rezolute are distributed in USD.
Stock savings plans offer an attractive way for investors to build wealth over the long term. One of the main advantages is the so-called cost-average effect: by regularly investing a fixed amount in stocks or stock funds, you automatically buy more shares when prices are low, and fewer when they are high. This can lead to a more favorable average price per share over time. In addition, stock savings plans allow small investors access to expensive stocks, as they can participate with small amounts. Regular investment also promotes a disciplined investment strategy and helps to avoid emotional decisions, such as impulsive buying or selling. Furthermore, investors benefit from the potential appreciation of the stocks as well as from dividend distributions, which can be reinvested, enhancing the compounding effect and thus the growth of the invested capital.
Andere Kennzahlen von Rezolute
Our stock analysis for Rezolute Revenue stock includes important financial indicators such as revenue, profit, P/E ratio, P/S ratio, EBIT, as well as information on dividends. We also assess aspects such as stocks, market capitalization, debt, equity, and liabilities of Rezolute Revenue. If you are looking for more detailed information on these topics, we offer comprehensive analyses on our subpages.
